ARHGDIB and gastric cancer: We also suggested that the ectopic expression of 14-3-3σ could activate Erk and p38 MAPK, and that suppression of 14-3-3σ-mediated Erk and p38 activation is critical for the cisplatin resistance of RhoGDI2-overexpressing gastric cancer cells.